Novatek Announces Addition of QSV Biologics to Prestigious List of Clients
Montreal, Canada, April 03, 2005 --(PR.com)-- Novatek International, known worldwide for leadership in pioneering 21 CFR Part II compliant solutions for the entire product life cycle of healthcare quality operations, is pleased to announce the addition of QSV Biologics to their prestigious list of clients.
QSV Biologics, a leading contract manufacturer providing mammalian cell culture and microbial fermentation services for the production of protein therapeutics, vaccines, and diagnostics, has selected Novatek’s Environmental Monitoring program to capture, manage, report and trend all environmental and utility data in a fully compliant and validated system.
QSV Biologics joins the long list of companies using Novatek’s Environmental Monitoring program, a list including such distinguished companies as Bristol Meyers Squibb, Johnson & Johnson, Irvine Analytical Laboratories, Cangene Corporation, and Sicor to name a few.
QSV Biologics, a leading contract manufacturer providing mammalian cell culture and microbial fermentation services for the production of protein therapeutics, vaccines, and diagnostics, has selected Novatek’s Environmental Monitoring program to capture, manage, report and trend all environmental and utility data in a fully compliant and validated system.
QSV Biologics joins the long list of companies using Novatek’s Environmental Monitoring program, a list including such distinguished companies as Bristol Meyers Squibb, Johnson & Johnson, Irvine Analytical Laboratories, Cangene Corporation, and Sicor to name a few.